Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRP | O00591 | 2/20 | 0.45 |
| ▸ | GABRD | O14764 | 2/20 | 0.45 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.45 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.45 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.45 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.45 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.45 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.45 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.45 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.45 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.45 |
| ▸ | GABRE | P78334 | 2/20 | 0.45 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.45 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.45 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.45 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28038601 | 0.87 | TET2 (0.48) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL7605161 | 0.78 | SLC22A6 (0.52) | TSHRFFAR3GPR84 | |
| SCHEMBL4326835 | 0.77 | CYP3A4 (0.45) | CYP1A2CYP3A4CYP2C19TSHRMEN1 | |
| SCHEMBL15654713 | 0.77 | CYP1A2 (0.42) | CYP1A2CYP3A4CYP2C19KDM2ATSHR | |
| Acetic Acid SCHEMBL4212999 | 0.76 | GPR84 (0.44) | CYP1A2CYP3A4CYP2C19FFAR4FFAR1 | |
| SCHEMBL3503355 | 0.75 | USP2 (0.42) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL29429 | 0.75 | — | — | |
| SCHEMBL4748796 | 0.75 | — | — | |
| SCHEMBL437065 | 0.75 | — | — | |
| SCHEMBL4287127 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160024327-A1 | DISPERSED COMPOSITION, COATING COMPOSITION, COATING FILM, AND COLORED ITEM | TOYO INK HOLDINGS CO., LTD. (JP) | 2016-01-28 | — | — | US | disclosed |
| US-20050107501-A1 | Compound resin molding and process for producing the same | SUZUKA FUJI XEROX CO., LTD. (JP) | 2005-05-19 | — | — | US | disclosed |
| EP-1466723-A1 | COMPOSITE RESIN MOLDING AND PROCESS FOR PRODUCING THE SAME | Suzuka Fuji Xerox Co., Ltd. (JP) | 2004-10-13 | — | — | EP | disclosed |
| US-5728685-A | SELECTIN RECEPTORS FOR INFLAMMATION MODULATORS | GLYCOMED INCORPORATED (US) | 1998-03-17 | — | — | US | disclosed |
| EP-0743951-A4 | SUBSTITUTED LACTOSE DERIVATIVES AS CELL ADHESION INHIBITORS | GLYCOMED INC (US) | 1997-03-19 | — | — | EP | disclosed |
| US-5591835-A | BIND TO RECEPTORS AND MODULATE INFLAMMATION, CANCER, AND RELATED DISEASES BY MODULATING CELL-CELL ADHESION EVENTS | GLYCOMED INCORPORATED (US) | 1997-01-07 | — | — | US | disclosed |
| EP-0743951-A1 | SUBSTITUTED LACTOSE DERIVATIVES AS CELL ADHESION INHIBITORS | GLYCOMED INCORPORATED (US) | 1996-11-27 | — | — | EP | disclosed |
| WO-1995021180-A1 | SUBSTITUTED LACTOSE DERIVATIVES AS CELL ADHESION INHIBITORS | GLYCOMED INCORPORATED (US) | 1995-08-10 | — | — | WO | disclosed |